Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Annals of General Psychiatry|June 22, 2022
Emotional blunting in patients with depression. Part IV: differences between patient and physician perceptionsMichael Cronquist Christensen, Hongye Ren, Andrea Fagiolini
Annals of General Psychiatry|June 20, 2022
Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of lifeMichael Cronquist Christensen, Hongye Ren, Andrea Fagiolini
Annals of General Psychiatry|June 21, 2022
Emotional blunting in patients with depression. Part III: relationship with psychological traumaMichael Cronquist Christensen, Hongye Ren, Andrea Fagiolini
Annals of General Psychiatry|April 5, 2022
Emotional blunting in patients with depression. Part I: clinical characteristicsMichael Cronquist Christensen, Hongye Ren, Andrea Fagiolini
Plos One|October 24, 2018
Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in ChinaShun Lu, Yongfeng Yu, Shijun Fu, et al.
International Journal of Biological Macromolecules|February 5, 2025
Preparation and characterization of multifunctional cellulose-based materials modified by hyperbranched polyamideHongye Ren, Zhimeng Zhao, Junlong Gao, et al.
Neuropsychiatric Disease and Treatment|March 28, 2020
Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT StudyGang Wang, Kristin Hui Xian Tan, Hongye Ren, et al.
Neuropsychiatric Disease and Treatment|September 7, 2022
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE StudyMircea Polosan, Marc Rabbani, Michael Cronquist Christensen, et al.
Current Medical Research and Opinion|July 7, 2023
Semaglutide versus tirzepatide for people with type 2 diabetes: cost of glycemic control in Austria, the Netherlands, Lithuania, and the United Arab EmiratesSigne Baattrup Reitzel, Mette Bøgelund, Amaury Basse, et al.
Current Medical Research and Opinion|March 8, 2023
Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studiesGregory W Mattingly, Oscar Necking, Simon Nitschky Schmidt, et al.
Pageof 3